Cargando…
New Markers of Renal Failure in Multiple Myeloma and Monoclonal Gammopathies
Multiple myeloma (MM) is a common plasma cell malignancy, which is responsible for significant mortality, often related to severe renal impairment (RI). Kidney injury can limit therapeutic choices and may often translate into poor outcomes, but it remains potentially reversible in a proportion of pa...
Autores principales: | Woziwodzka, Karolina, Vesole, David H., Małyszko, Jolanta, Batko, Krzysztof, Jurczyszyn, Artur, Koc-Żórawska, Ewa, Krzanowski, Marcin, Małyszko, Jacek, Żórawski, Marcin, Waszczuk-Gajda, Anna, Kuźniewski, Marek, Krzanowska, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355449/ https://www.ncbi.nlm.nih.gov/pubmed/32486490 http://dx.doi.org/10.3390/jcm9061652 |
Ejemplares similares
-
Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple Myeloma
por: Banaszkiewicz, Małgorzata, et al.
Publicado: (2020) -
New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia
por: Banaszkiewicz, Małgorzata, et al.
Publicado: (2019) -
Transgelin-2 in Multiple Myeloma: A New Marker of Renal Impairment?
por: Woziwodzka, Karolina, et al.
Publicado: (2021) -
Renal Impairment Detectors: IGFBP-7 and NGAL as Tubular Injury Markers in Multiple Myeloma Patients
por: Woziwodzka, Karolina, et al.
Publicado: (2021) -
The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment
por: Banaszkiewicz, Małgorzata, et al.
Publicado: (2022)